aTyr Pharma enters into $65M at-the-market offering agreement with Jefferies, terminates prior JonesTrading ATM

aTYR PHARMA INC

aTyr Pharma entered into Open Market Sale Agreement with Jefferies LLC to sell up to $65M of common stock at market prices on Nasdaq.
The agreement includes a 3.0% commission to Jefferies on gross proceeds from each sale of shares.
Company terminated the prior Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC dated March 23, 2021.
Prior agreement allowed up to $25M in common stock sales through JonesTrading as sales agent.
Shares will be sold under existing shelf registration statement (File No. 333-250095) effective November 23, 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.